Table 4.
Population and Gene |
SNP | Chr | Base Pair Position |
Minor Allele |
MAF | β (%/yr)b | P Value | Genetic Modelc |
---|---|---|---|---|---|---|---|---|
African Americans | ||||||||
GLRX2 | rs35358794 | 1 | 191336492 | A | 0.06 | 0.29 ± 0.09 | 0.001 | Additive |
SOD2 | rs4342445 | 6 | 160018212 | A | 0.15 | −0.53 ± 0.17 | 0.002 | Recessive |
TXN2 | rs2267337 | 22 | 35200417 | T | 0.22 | −0.16 ± 0.05 | 0.002 | Additive |
TXN2 | rs2281082 | 22 | 35202696 | T | 0.22 | −0.15 ± 0.05 | 0.004 | Additive |
PRDX4 | rs528960 | 23 | 23601182 | C | 0.24 | 0.19 ± 0.06 | 0.003 | Dominant |
European Americans | ||||||||
GCLC | rs17883901 | 6 | 53517996 | T | 0.09 | −0.86 ± 0.21 | 4.50 × 10−5 | Recessive |
GSTO2 | rs157077 | 10 | 106027884 | C | 0.46 | −0.09 ± 0.03 | 3.68 × 10−4 | Additive |
Abbreviations: FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; SNP, single nucleotide polymorphism; Chr, chromosome; MAF, minor allele frequency; β, regression coefficient; GLRX2, glutaredoxin 2; SOD2, superoxide dismutase 2; TXN2, thioredoxin 2; PRDX4, peroxiredoxin 4; GCLC, glutamate-cysteine ligase (catalytic subunit); GSTO2, glutathione S-transferase O2.
Data shown for associations with P < 0.005 for the SNP single-marker effect on rate of change in FEV1/FVC, sorted by race/ethnicity, chromosome and base pair position. Statistically significant associations satisfying the Bonferroni-adjusted threshold (African Americans: P < 2.3 × 10−4; European Americans: P < 3.0 × 10−4) are bolded.
Regression coefficient and standard error for the SNP × time product term in the corresponding mixed effects model.
Genetic model is defined in reference to the minor allele for each SNP.